近赤外線（NIR） およびラマン分光市場は2030 年までに31 億 5,222 万ドルに達し、2022 年から 2030 年までに11.72% の CAGR で成長すると予測されます。慢性疾患とは、長期間にわたって続く疾患です。Centers for Disease Control and Prevention によると、2019 年の世界中の成人の慢性疾患の有病率は 60% を超えており、明らかに高齢者の割合が非常に高くなっています。近赤外線 (NIR) 分光法は、がんやその他の慢性疾患の機能診断と治療モニタリングのための迅速、簡単、ポータブル、非侵襲性、および手頃な価格の技術です。オキシヘモグロビンまたはデオキシヘモグロビン、脂質または水のバンド、またはその両方を使用して、癌組織と正常組織間の内因性発色団の変動に基づいています。
慢性疾患の有病率の上昇、プロセス分析技術 (PAT) 機器の需要の増加、NIR およびラマン分光技術の向上によって、市場は拡大しています。また、クラウドベースの分光法への関心が高まっているため、市場は将来的に成長する余地があります。ただし、熟練した経験豊富な専門家の不在が、予測期間全体にわたって市場の成長を抑制する可能性があります。
目次
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 GROWING DEMAND FOR PROCESS ANALYTICAL TECHNOLOGY (PAT) TOOLS
4.2.3 TECHNOLOGICAL ADVANCEMENTS IN NIR AND RAMAN SPECTROSCOPY
4.3 RESTRAINTS
4.3.1 SHORTAGE OF SKILLED AND EXPERIENCED PROFESSIONALS
4.4 OPPORTUNITY
4.4.1 RISING DEMAND FOR CLOUD-BASED SPECTROSCOPY
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRICING
5.3.3 IMPACT ON KEY PLAYERS
5.4 NIR AND RAMAN SPECTROSCOPY AS FOR PROCESS ANALYTICAL TECHNOLOGY (PAT) TOOLS
6 GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET BY PRODUCT
6.1 OVERVIEW
6.2 NEAR-INFRARED SPECTROSCOPY
6.2.1 SCANNING
6.2.2 FOURIER-TRANSFORM
6.2.3 FILTER OR AOTF
6.3 RAMAN SPECTROSCOPY
6.3.1 MICRO-RAMAN SPECTROSCOPY
6.3.2 PROBE-BASED RAMAN SPECTROSCOPY
6.3.3 FT-RAMAN SPECTROSCOPY
6.3.4 OTHERS
7 GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET BY APPLICATION
7.1 OVERVIEW
7.2 PHARMACEUTICAL APPLICATIONS
7.3 BIOTECHNOLOGY & BIOPHARMACEUTICAL APPLICATIONS
7.4 FOOD & BEVERAGE TESTING
7.5 ENVIRONMENT TESTING
7.6 ACADEMIC RESEARCH
7.7 OTHERS
8 GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 UK
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 CHINA
8.4.2 INDIA
8.4.3 JAPAN
8.4.4 AUSTRALIA
8.4.5 SOUTH KOREA
8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
8.5.1 MIDDLE EAST
8.5.2 AFRICA
8.5.3 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MAJOR GROWTH STRATEGY IN GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET
9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET
9.5 KEY DEVELOPMENT ANALYSIS
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
9.6.2 PARTNERSHIP/COLLABORATION
9.6.3 MERGERS & ACQUISITIONS
9.7 MAJOR PLAYERS SALES ANALYSIS
9.7.1 SALES & OPERATING INCOME
9.8 MAJOR PLAYERS R&D ANALYSIS
9.8.1 R&D EXPENDITURE
10 COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC INC.
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL ANALYSIS
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 BRUKER
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIES
10.3 PERKINELMER INC.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS 0FFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIES
10.4 AGILENT TECHNOLOGIES, INC.
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGIES
10.5 JASCO
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL ANALYSIS
10.5.3 PRODUCTS/SERVICES OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIES
10.6 SHIMADZU CORPORATION
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 KEY STRATEGIES
10.7 DANAHER
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 MERCK KGAA
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 ABB
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIES
10.10 HORIBA, LTD
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 APPENDIX
11.1 REFERENCES
11.2 RELATED REPORTS
?
